These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2200619)

  • 21. Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM.
    Haffner SM; Bowsher RR; Mykkänen L; Hazuda HP; Mitchell BD; Valdez RA; Gingerich R; Monterossa A; Stern MP
    Diabetes; 1994 Dec; 43(12):1490-3. PubMed ID: 7958504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.
    Polonsky KS; Gumbiner B; Ostrega D; Griver K; Tager H; Henry RR
    Diabetes; 1994 Jul; 43(7):871-7. PubMed ID: 8013750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct measurement of plasma proinsulin in normal and diabetic subjects.
    Duckworth WC; Kitabchi AE
    Am J Med; 1972 Oct; 53(4):418-27. PubMed ID: 4672850
    [No Abstract]   [Full Text] [Related]  

  • 24. A direct assay for proinsulin in plasma and its applications in hypoglycaemia.
    Hampton SM; Beyzavi K; Teale D; Marks V
    Clin Endocrinol (Oxf); 1988 Jul; 29(1):9-16. PubMed ID: 3073882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sensitive and reliable method for assaying true human insulin without interaction with human proinsulin-like molecules.
    Monti LD; Sandoli EP; Phan VC; Piatti PM; Costa S; Secchi A; Pozza G
    Acta Diabetol; 1995 Mar; 32(1):57-63. PubMed ID: 7612920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A soluble-phase proinsulin radioimmunoassay and its use in diagnosis of hypoglycaemia.
    Naylor BA; Matthews DR; Turner RC
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():352-63. PubMed ID: 3310832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of plasminogen activator inhibitor-1 activity in survivors of myocardial infarction.
    Gray RP; Mohamed-Ali V; Patterson DL; Yudkin JS
    Thromb Haemost; 1995 Feb; 73(2):261-7. PubMed ID: 7792741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE; Halban PA
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.
    Sobey WJ; Beer SF; Carrington CA; Clark PM; Frank BH; Gray IP; Luzio SD; Owens DR; Schneider AE; Siddle K
    Biochem J; 1989 Jun; 260(2):535-41. PubMed ID: 2669734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperproinsulinemia of type II diabetes is not present before the development of hyperglycemia.
    Birkeland KI; Torjesen PA; Eriksson J; Vaaler S; Groop L
    Diabetes Care; 1994 Nov; 17(11):1307-10. PubMed ID: 7821172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction.
    Gray RP; Panahloo A; Mohamed-Ali V; Patterson DL; Yudkin JS
    Atherosclerosis; 1997 Apr; 130(1-2):171-8. PubMed ID: 9126661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes.
    Dornhorst A; Davies M; Anyaoku V; Hampton SM; Elkeles RS; Beard RW; Johnston DG
    Clin Endocrinol (Oxf); 1991 Mar; 34(3):211-3. PubMed ID: 2036730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proinsulin and insulin concentrations following intravenous glucose challenges in normal, obese, and non-insulin-dependent diabetic subjects.
    Davis SN; Piatti PM; Monti L; Brown MD; Branch W; Hales CN; Alberti KG
    Metabolism; 1993 Jan; 42(1):30-5. PubMed ID: 8446045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.
    Tan KC; Cooper MB; Ling KL; Griffin BA; Freeman DJ; Packard CJ; Shepherd J; Hales CN; Betteridge DJ
    Atherosclerosis; 1995 Mar; 113(2):273-87. PubMed ID: 7605366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher proinsulin and specific insulin are both associated with a parental history of diabetes in nondiabetic Mexican-American subjects.
    Haffner SM; Stern MP; Miettinen H; Gingerich R; Bowsher RR
    Diabetes; 1995 Oct; 44(10):1156-60. PubMed ID: 7556950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance.
    Ward WK; LaCava EC; Paquette TL; Beard JC; Wallum BJ; Porte D
    Diabetologia; 1987 Sep; 30(9):698-702. PubMed ID: 3322910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men.
    Vangipurapu J; Stančáková A; Kuulasmaa T; Kuusisto J; Laakso M
    PLoS One; 2015; 10(4):e0124028. PubMed ID: 25853252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients.
    Coifman R; Dalbosco IS; Russo EM; Moisés RS
    Braz J Med Biol Res; 1999 Jan; 32(1):67-72. PubMed ID: 10347771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.